Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The potential of immune biomarkers to advance personalized medicine approaches for schizophrenia.

The Journal of nervous and mental disease - 1 May 2015

Cox David, Chan Man K, Bahn Sabine

Abstract excerpt

Molecular profiling studies have helped increase the understanding of the immune processes thought to be involved in the etiology and pathophysiology of psychiatric disorders such as schizophrenia. Current therapeutic interventions with first- and second-generation antipsychotics are suboptimal. Poor response rates and debilitating side effects often lead to poor treatment compliance. This highlights the pressing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Inflammatory Agents
Share to Antipsychotic Agents
Share to Biomarkers

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to Inflammation Mediators

Share to Precision Medicine

Share to Schizophrenia

Share to Schizophrenic Psychology

Source

Identifiers

PMID: 25919386
DOI: 10.1097/NMD.0000000000000289

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The potential of immune biomarkers to advance personalized medicine approaches for schizophrenia.PMID 25919386Read ↗

Autoimmune phenotypes in schizophrenia reveal novel treatment targets.Semantic proximity Read ↗

Genetic Evidence for a Neuroimmune Model of Schizophrenia.Semantic proximity Read ↗

Variation in the major histocompatibility complex [MHC] gene family in schizophrenia: associations and functional implications.Semantic proximity Read ↗

Immunogenetic Variants in Major Mental and Neurodevelopmental Disorders.Semantic proximity Read ↗

Altered immune function in unaffected first-degree biological relatives of schizophrenia patientsSemantic proximity Read ↗

Immune system disturbances in schizophrenia.Semantic proximity Read ↗

Consensus on potential biomarkers developed for use in clinical tests for schizophreniaSemantic proximity Read ↗

An Update on Promising Biomarkers in SchizophreniaSemantic proximity Read ↗

Genome-wide association studies suggest limited immune gene enrichment in schizophrenia compared to five autoimmune diseasesSemantic proximity Read ↗

A subtype of schizophrenia patients with altered methylation level of genes related to immune cell activitySemantic proximity Read ↗

Associations between SNPs and immune-related circulating proteins in schizophrenia.Semantic proximity Read ↗

Immunological protein profiling of first-episode psychosis patients identifies CSF and blood biomarkers correlating with disease severitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.